All In Biotech

Drug Trial Radar · NCT01446679

Special Drug Use-Results Survey of Lipitor Tablets

Last checked: Nov 19, 2026Latest source record: Feb 21, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24,050

Actual

Start

Sep 2010

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
First posted
Oct 5, 2011

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to evaluate the controlling effect of atrovastatin on plasma lipid to achieve the category-specific targeted lipid levels.

Conditions

  • Hypercholesterolemia

Interventions

  • atrovastatinDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in plasma LDL-C concentrationTime frame: 0, 4, 12 and 24 week
  2. Change in rate of achievement of the category-specific target LDL-C levelTime frame: 0, 4, 12 and 24 week

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Chūbu, Japan

  • Site not named

    Chugoku, Japan

  • Site not named

    Hokkaido, Japan

  • Site not named

    Kansai, Japan

  • Site not named

    Kantou, Japan

  • Site not named

    Kyushu, Japan

  • Site not named

    Shikoku, Japan

  • Site not named

    Tōhoku, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.